INVESTOR INTELLIGENCE

The Daily Briefing

Biotech news, drug catalysts, and the market moves that matter.

LEAD STORY
REGULATORY INTELLIGENCE

Regeneron wins FDA approval for first RNAi drug in its portfolio

The Alnylam collaboration brings a new competitor to the myasthenia gravis market.

BioPharma Dive Nov 19REGN
THE NEWSROOM

Latest Intelligence